Abstract
The invention relates to methods of treating cognitive dysfunction and improving cognitive functioning comprising the administration of trans-4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a pharmaceutically acceptable salt thereof to a patient in need thereof. Moreover the invention relates to an improved binder in a composition comprising 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine.
Original language | English |
---|---|
IPC | A61P 25/ 18 A I |
Patent number | US2011207744 |
Country/Territory | Denmark |
Priority date | 05/05/2011 |
Priority number | US201113101176 |
Publication status | Published - 25. Aug 2011 |
Externally published | Yes |